Export

Farmastat Norsk Legemiddelstatistikk AS

Financial information

The information source is the annual report of the company with business id 970 983 082

* Closing information (×1000) NOK

Fiscal year 202312 202212
Turnover: 21,612 Revenue Up 20,514 Revenue Down
Financial expenses: 120 Revenue Up 76 Revenue Up
Earnings before taxes: -477 Revenue Down 32 Revenue Down
Total assets: 11,357 Revenue Down 12,398 Revenue Down
Current assets: 6,825 Revenue Down 8,013 Revenue Down
Current liabilities: 3,407 Revenue Down 3,933 Revenue Down
Equity capital: 7,773 Revenue Down 8,178 Revenue Up
Share capital: 2,000 2,000

Financial ratios

Solvency: 68.4% Revenue Up 66.0% Revenue Up
Profitability: -2.2% Revenue Down 0.2% Revenue Down
Return on equity (ROE): -6.1% Revenue Down 0.4% Revenue Down
Current ratio: 200.3% Revenue Down 203.7% Revenue Up
Return on assets (ROA): -3.1% Revenue Down 0.9% Revenue Down
Fiscal year 202312
Turnover: 21,612
Financial expenses: 120
Earnings before taxes: -477
Total assets: 11,357
Current assets: 6,825
Current liabilities: 3,407
Equity capital: 7,773
Share capital: 2,000

Financial ratios

Solvency: 68.4%
Profitability: -2.2%
Return on equity (ROE): -6.1%
Current ratio: 200.3%
Return on assets (ROA): -3.1%